Aptevo Therapeutics (APVO) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…

Aptevo Therapeutics (APVO) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: February 10, 2025 (12:26)

Sector: Healthcare

The share price of Aptevo Therapeutics Inc. (APVO) now

Latest session on the 10th of February for
Aptevo Therapeutics Inc. is negative
Trading Volume: 19534
Open: 4.07 /  High: 4.07 /  Low: 3.809
Current value: $3.91
What analysts predict: $21
52-week High/Low: $399.6 / $3.65
50-Day Moving Average: $6.04 — resistance level today
200-Day Moving Average: $13.96 — resistance level today

Are you interested in Aptevo Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aptevo Therapeutics stock price in 2025, 2026, 2027. How much will one Aptevo Therapeutics share be worth in 2025 - 2027?

When should I take profit in Aptevo Therapeutics stock? When should I record a loss on Aptevo Therapeutics stock? What are analysts' forecasts for Aptevo Therapeutics stock? What is the future of Aptevo Therapeutics stock? We forecast Aptevo Therapeutics stock performance using neural networks based on historical data on Aptevo Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Aptevo Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aptevo Therapeutics shares. This happens once a day.


Historical and forecast chart of Aptevo Therapeutics stock

The chart below shows the historical price of Aptevo Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Aptevo Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Aptevo Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. The company develops its drug candidates using its ADAPTIR platform. The products under its pipeline are APVO436, which targets CD123 and CD3 and redirects T-cell cytotoxicity to the tumor; ALG.APV-527, for the treatment of a broad spectrum of cancers over-expressing the 5T4 tumor antigen, including mesothelioma, non-small-cell-lung, head & neck, pancreatic, renal, ovarian, and bladder cancers; and APVO603.

Trending Themes in the Healthcare Sector

Aptevo Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 12 3.50 3.17 3.72 17.34
Feb 13 3.56 3.35 3.97 18.37
Feb 14 3.78 3.41 4.15 21.85
Feb 15 3.29 3.09 3.59 16.21
Feb 16 3.68 3.46 4.05 17.21
Feb 17 4.21 4.04 4.72 17.00
Feb 18 3.97 3.51 4.22 20.47
Feb 19 3.90 3.57 4.08 14.34
Feb 20 3.68 3.50 3.91 11.62
Feb 21 3.15 2.90 3.29 13.19
Feb 22 2.91 2.82 3.22 14.24
Feb 23 2.99 2.65 3.13 18.02
Feb 24 2.84 2.55 3.07 20.25
Feb 25 2.93 2.76 3.03 9.86
Feb 26 3.05 2.75 3.32 20.57
Feb 27 2.82 2.72 2.97 9.47
Feb 28 2.68 2.43 2.99 23.14
Mar 01 2.51 2.43 2.70 10.91
Mar 02 2.19 1.97 2.45 24.42
Mar 03 2.31 2.11 2.55 20.63
Mar 04 2.31 2.23 2.49 11.61
Mar 05 2.38 2.23 2.64 18.49
Mar 06 2.38 2.15 2.57 19.54
Mar 07 2.69 2.56 3.01 17.48
Mar 08 3.00 2.66 3.18 19.46
Mar 09 3.03 2.77 3.31 19.61
Mar 10 3.27 3.00 3.63 20.94
Mar 11 2.88 2.66 3.23 21.66
Mar 12 2.57 2.48 2.83 13.76
Mar 13 2.48 2.39 2.58 8.13

Aptevo Therapeutics Daily Price Targets


Aptevo Therapeutics Stock Forecast 02-12-2025.

Forecast target price for 02-12-2025: $3.50.
Negative dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 14.781%.
Pessimistic target level: 3.17
Optimistic target level: 3.72

Aptevo Therapeutics Stock Forecast 02-13-2025.

Forecast target price for 02-13-2025: $3.56.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 15.517%.
Pessimistic target level: 3.35
Optimistic target level: 3.97

Aptevo Therapeutics Stock Forecast 02-14-2025.

Forecast target price for 02-14-2025: $3.78.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 17.930%.
Pessimistic target level: 3.41
Optimistic target level: 4.15

Aptevo Therapeutics Stock Forecast 02-15-2025.

Forecast target price for 02-15-2025: $3.29.
Negative dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 13.950%.
Pessimistic target level: 3.09
Optimistic target level: 3.59

Aptevo Therapeutics Stock Forecast 02-16-2025.

Forecast target price for 02-16-2025: $3.68.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 14.680%.
Pessimistic target level: 3.46
Optimistic target level: 4.05

Aptevo Therapeutics Stock Forecast 02-17-2025.

Forecast target price for 02-17-2025: $4.21.
Positive dynamics for Aptevo Therapeutics shares will prevail with possible volatility of 14.530%.
Pessimistic target level: 4.04
Optimistic target level: 4.72

APVO (APVO) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Mar. -2.53 -8.23 13.22 162.28
Apr. -0.25 -0.78 1.17 166.27
May. -0.51 -3.19 1.79 277.45
Jun. 3.09 -12.52 15.07 183.08
Jul. 11.17 -25.14 58.56 142.92
Aug. -24.13 -93.85 119.67 178.42
Sep. -11.06 -56.98 35.86 258.87
Oct. 17.90 -24.12 76.07 131.71
Nov. -35.43 -243.39 73.35 431.83
Dec. 118.14 -617.95 566.20 209.14

Aptevo Therapeutics forecast for this year


Aptevo Therapeutics Stock Prediction for Mar 2025

An downtrend is forecast for this month with an optimal target price of $-2.52662. Pessimistic: $-8.23. Optimistic: $13.22


Aptevo Therapeutics Stock Prediction for Apr 2025

An uptrend is forecast for this month with an optimal target price of $-0.245082. Pessimistic: $-0.78. Optimistic: $1.17


Aptevo Therapeutics Stock Prediction for May 2025

An downtrend is forecast for this month with an optimal target price of $-0.510652. Pessimistic: $-3.19. Optimistic: $1.79


Aptevo Therapeutics Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $3.08608. Pessimistic: $-12.52. Optimistic: $15.07


Aptevo Therapeutics Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $11.1676. Pessimistic: $-25.14. Optimistic: $58.56


Aptevo Therapeutics Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $-24.1276. Pessimistic: $-93.85. Optimistic: $119.67


Aptevo Therapeutics Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $-11.0553. Pessimistic: $-56.98. Optimistic: $35.86


Aptevo Therapeutics Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $17.8951. Pessimistic: $-24.12. Optimistic: $76.07


Aptevo Therapeutics Stock Prediction for Nov 2025

An downtrend is forecast for this month with an optimal target price of $-35.4306. Pessimistic: $-243.39. Optimistic: $73.35


Aptevo Therapeutics Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $118.14. Pessimistic: $-617.95. Optimistic: $566.20



Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 192.82 -1 060.80 1 045.97 201.42
Feb -1 269.73 -4 136.15 4 807.07 186.04
Mar -8.51 -62.28 39.12 259.20
Apr -36.93 -227.02 153.16 248.23
May -273.70 -1 534.19 566.62 370.76
Jun -298.42 -2 427.25 1 048.94 331.40
Jul -1 268.52 -9 401.38 4 687.94 300.54
Aug 678.79 -608.40 2 762.79 122.02
Sep 3 927.38 -21 606.90 14 212.00 252.03
Oct 2 863.45 -11 875.00 9 327.70 227.31
Nov -7 220.77 -39 170.50 35 161.60 211.40
Dec -3 960.59 -30 068.40 13 563.80 321.68

Aptevo Therapeutics (APVO) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 14 279.10 -43 744.10 112 274.00 138.96
Feb 87 775.20 -379 865.00 682 233.00 155.68
Mar 317 632.00 -1 776 170.00 2 612 210.00 167.99
Apr 1 550 970.00 -3 490 920.00 11 494 700.00 130.37
May -3 911 070.00 -31 811 500.00 4 565 000.00 796.86
Jun 23 283 000.00 -140 709 000.00 80 049 300.00 275.78
Jul 67 434 600.00 -176 139 000.00 323 187 000.00 154.50
Aug -340 551 000.00 -2 800 690 000.00 1 443 050 000.00 294.08
Sep -986 339 000.00 -3 302 060 000.00 5 337 380 000.00 161.87
Oct -5 706 860 000.00 -42 810 600 000.00 32 942 800 000.00 229.95
Nov -5 191 530 000.00 -20 193 000 000.00 26 217 700 000.00 177.02
Dec -7 066 710 000.00 -21 105 400 000.00 6 972 010 000.00 402.72

Aptevo Therapeutics information and performance

Aptevo Therapeutics Address

2401 4TH AVE., SUITE 1050, SEATTLE, WA, US

Market Capitalization: 5 833 800 $

Market capitalization of the Aptevo Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of APVO shares in the company outstanding by the market price of one share.

EBITDA: -24 207 000 $

EBITDA of Aptevo Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -415.99

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -1
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 3.945

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.122

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.386

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1458400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Aptevo Therapeutics (APVO) stock dividend

Aptevo Therapeutics last paid dividends on 01/01/1970. The next scheduled payment will be on 03/27/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.

FAQ (Frequently Asked Questions about Aptevo Therapeutics Stock)

Should I Buy Aptevo Therapeutics Shares in 2025 year?

The maximum forecasted share price for next year is $3 927.38, which is $3 923.34 higher than the current stock price. By investing in Aptevo Therapeutics shares today for a one-year period, you could achieve a profit of 97 112.44%. With an investment horizon of up to two years, the target share price is $67 434 568.00. resulting in a profit of 1 669 172 375.25% ($67 434 563.96 per share).

Does Aptevo Therapeutics pay dividends?

No, it does not

Which economic sector do Aptevo Therapeutics's shares belong to?

Aptevo Therapeutics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Aptevo Therapeutics's shares?

You can view all the stocks that are part of the same sector as Aptevo Therapeutics's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.